DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$7.49
+0.07 (+0.94%)
As of Aug 15, 2:18 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +309.7% upside
Low Target $21.79
Average Target $30.69
High Target $37.55
Current Price $7.49
Current
$7.49
Target
$30.69
$21.79 $30.69 avg $37.55
Scenario Analysis
Bear Case
$21.79
190.9%
Low target
Base Case
$30.69
+309.7%
Avg target
Bull Case
$37.55
+401.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.62
-22.1% from high
52-Week Low
$3.53
+112.2% from low
Target vs 52W High
$30.69
+219.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%